Skip to content

Clinical trials

Hemoglobinuria, Paroxysmal trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemoglobinuria, Paroxysmal Country / region: France Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20051
20121
20163
20171
20183
20192
20203
20215
20221
20234
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Active, not recruiting5
Recruiting3
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alexion Pharmaceuticals, Inc.13
Novartis Pharmaceuticals5
Hoffmann-La Roche3
Apellis Pharmaceuticals, Inc.2
BioCryst Pharmaceuticals2
Amgen1
Assistance Publique - Hôpitaux de Paris1
Swedish Orphan Biovitrum1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemoglobinuria, Paroxysmal28
Hemolysis5
Anemia3
Anemia, Hemolytic1
Atypical Hemolytic Uremic Syndrome1
Myasthenia Gravis1
Neuromyelitis Optica1

Trials

Showing 26 to 28 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.